ANNYSUE EMMONS: Open Payments
NPI 1336606201 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 17 payments from 7 companies in 2025. Trend: 2023 $595 · 2024 $404 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Novo Nordisk Inc | 3 | $59 |
| Lilly USA, LLC | 3 | $57 |
| Boston Scientific Corporation | 1 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: UBRELVY, FARXIGA, MOUNJARO, WATCHMAN FLX, BREZTRI, Rybelsus, Ozempic, Wegovy.
Industry payments across TX — which companies pay providers there.
